Skip to content

Ghrelin Changes After Roux-en-Y Gastric Bypass

Ghrelin Changes After Roux-en-Y Gastric Bypass: Does Gastric Pouch vs. Gastric Remnant Feeding Affect Secretion?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00765596
Enrollment
14
Registered
2008-10-03
Start date
2005-01-31
Completion date
Unknown
Last updated
2011-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Obesity

Keywords

Obesity, Insulin resistance, Gastric tube, Ghrelin

Brief summary

The purpose of this study is to determine whether gastric division (via Roux-en-Y gastric bypass) with resultant fundic isolation will alter the pattern(s) of Ghrelin secretion in the early post-operative period following feeding in morbidly obese subjects.

Interventions

OTHERLiquid diet for 3 days

The control group were given a 3 -day liquid diet similar to the RYGB post-op diet

Sponsors

Vanderbilt University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Serum creatinine and liver function tests \< upper limits of normal * Stable body weights for the past three months * Women will have a negative pregnancy test * patients who are already scheduled for RYGB with gastrostomy tube placement

Exclusion criteria

* Significant hepatic enzyme elevations (more than 100% of upper limits of normal) * Serum creatinine \> 1.5 mg/dl * history of ketoacidosis or current metabolic acidosis * current use of oral anticoagulants * Positive pregnancy test (beta-human chorionic gonadotrophin) for females * intercurrent infections * patients with prior gastric operations

Design outcomes

Primary

MeasureTime frame
Ghrelinpre-op, peri-op, immediately post-op, 2 days, 3 wks, 6wks, 6mos, 1 year post op

Secondary

MeasureTime frame
HOMApre-op, peri-op, immediately post-op, 2 days, 3 wks, 6wks, 6mos, 1 year post op
metabolic hormonespre-op, peri-op, immediately post-op, 2 days, 3 wks, 6wks, 6mos, 1 year post op

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026